1. Cho KM, Park H, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ.Skeletal muscle depletion predicts survival of patients with advanced biliary tract cancer undergoing palliative chemotherapy. Oncotarget. 2017 Jun 2;8(45)

2. Cho KM, Park H, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ.Neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and their dynamic changes during chemotherapy isuseful to predict a more accurate prognosis of advanced biliary tract cancer. Oncotarget. 2017 Jan 10;8(2)

3. Shahid M*, Cho KM*, Nguyen MN, Choi TG, Jo YH, Aryal SN, Yoo JY, Yun HR, Lee JW, Eun YG, Lee JS, Kang I, Ha J, Yoon HJ, Kim SY, Kim SS.Prognostic value and their clinical implication of 89-gene signature in glioma. Oncotarget. 2016 Aug; 9 7(32):

4. Cho KM, Oh DY, Kim TY, Lee KH, Han SW, Im SA, Kim TY, Bang YJ.Metabolic Characteristics of Advanced Biliary Tract Cancer Using18F-Fluorodeoxyglucose Positron Emission Tomography and Their Clinical Implications. Oncologist. 2015 Aug;20(8)

5. Cho KM, Kim YJ, Kim SH, Kim JW, Lee JO, Han JH, Lee KW, Kim JH, Kim CY, Bang SM, Kim IA, Kim JS, Lee JS. Salvage Treatment with Intracerebrospinal Fluid Thiotepa in Patients with Leptomeningeal Metastasis After Failure of Methotrexate-based Treatment. Anticancer Res. 2015 Oct;35(10):

6. Cho KM, Keam B, Kim TM, Lee SH, Kim DW, Heo DS.Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure. Korean J Intern Med. 2015 Nov;30(6):

7. Cho KM, Keam B, Kim TM, Lee SH, Kim DW, Heo DS.Clinical significance of rituximab infusion-related reaction in diffuse large B-cell lymphoma patients receiving R-CHOP.Korean J Intern Med. 2017 Nov 20

8. Nguyen MN, Choi TG, Nguyen DT, Kim JH, Jo YH, Shahid M, Akter S, Aryal SN, Yoo JY, Ahn YJ, Cho KM, Lee JS, Choe W, Kang I, Ha J, Kim SS.CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer. Oncotarget. 2015 Oct 13;6(31):